National Health Investors, Inc. (NYSE:NHI) Receives $85.57 Average Price Target from Brokerages

Shares of National Health Investors, Inc. (NYSE:NHI) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $85.5714.

Several equities analysts recently issued reports on NHI shares. Truist Financial upped their target price on National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a research report on Monday, December 15th. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a report on Monday, January 5th. KeyCorp boosted their target price on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. National Bank Financial set a $85.00 price target on National Health Investors in a research report on Tuesday, January 20th. Finally, Wells Fargo & Company lifted their price target on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th.

Institutional Investors Weigh In On National Health Investors

Hedge funds have recently modified their holdings of the company. Mercer Global Advisors Inc. ADV acquired a new stake in shares of National Health Investors during the 4th quarter valued at about $352,000. EP Wealth Advisors LLC acquired a new stake in National Health Investors in the fourth quarter valued at approximately $351,000. NewEdge Advisors LLC increased its position in shares of National Health Investors by 111.6% in the fourth quarter. NewEdge Advisors LLC now owns 10,202 shares of the real estate investment trust’s stock valued at $779,000 after buying an additional 5,380 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors in the fourth quarter valued at approximately $33,000. Finally, Voloridge Investment Management LLC raised its stake in shares of National Health Investors by 1.6% during the 4th quarter. Voloridge Investment Management LLC now owns 76,629 shares of the real estate investment trust’s stock worth $5,852,000 after buying an additional 1,238 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Stock Down 0.2%

NYSE:NHI opened at $88.59 on Friday. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74. National Health Investors has a twelve month low of $66.41 and a twelve month high of $91.38. The company has a market cap of $4.22 billion, a PE ratio of 27.94, a P/E/G ratio of 3.03 and a beta of 0.66. The company’s 50 day moving average is $80.68 and its two-hundred day moving average is $78.30.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.